3ꢀIndolizinꢀ2ꢀylquinoxalines
Russ.Chem.Bull., Int.Ed., Vol. 54, No. 11, November, 2005 2623
H(3´)); 12.54 (s, 1 H, NH). 13C NMR, δ: 98.74 (C(1´)), 110.84
(C(6´)), 114.81 (C(8)), 116.70 (C(3´)), 117.85 (C(7´)), 118.98
(C(8´)), 123.00 (C(6)), 123.66 (C(2´)), 125.91 (C(5´)), 127.81
(C(5)), 128.87 (C(7)), 131.01 (C(8a)), 131.68 (C(8a´)), 132.08
(C(4a)), 150.80 (C(3)), 154.00 (C(2)).
745, 762, 1021, 1082, 1089, 1098, 1135, 1187, 1251, 1274, 1285,
1309, 1422, 1497, 1602, 1652. 1H NMR, δ: 1.28 (dd, 3 H, CH3,
J = 7.04 and 6.63 Hz); 4.33 (dq, 2 H, CH2, J = 7.04 and
6.63 Hz); 6.64 (dd, 1 H, H(6´), J = 6.68 and 5.84 Hz); 6.75 (dd,
1 H, H(7´), J = 6.28 and 6.28 Hz); 7.20—7.60 (m, 10 H, Ph,
H(5), H(6), H(7), H(8), H(5´)); 8.37 (d, 1 H, H(5´), J =
7.04 Hz); 8.56 (s, 1 H, H(3´)).
3ꢀ(3ꢀPhenylindolizinꢀ2ꢀyl)quinoxalinꢀ2(1H )ꢀone (4b). Triꢀ
ethylamine (8 mL) was added to a mixture of compound 3b
(0.4 g, 0.083 mmol) and chloroform (32 mL). The reaction
mixture was stirred for 2 h and kept for 3 days. Then chloroform
and Et3N were evaporated in vacuo, and water (20 mL) was
added to the residue. The crystals that precipitated were filtered
off, washed with water, dried, suspended in chloroform (10 mL),
passed through a column (300×15 mm) packed with silica gel
(2 g), and eluted with chloroform (80 mL). The solvent was
evaporated in vacuo, and analytically pure compound 4b was
obtained in a yield of 0.2 g (71%), m.p. 243—245 °C. Found (%):
C, 74.65; H, 5.28; N, 14.43. C18H15N3O. Calculated (%):
C, 74.72; H, 5.23; N, 14.52. IR, ν/cm–1: 422, 472, 556, 594,
663, 702, 744, 769, 788, 912, 1149, 1176, 1276, 1317, 1490,
1544, 1597, 1666, 2500—3220. 1H NMR, δ: 6.64 (dd, 1 H,
H(6´), J = 6.80 and 6.76 Hz); 6.76 (dd, 1 H, H(7´), J = 6.76 and
6.08 Hz); 7.20 (dd, 1 H, H(6), J = 7.44 and 6.80 Hz); 7.26 (d,
1 H, H(8), J = 8.16 Hz); 7.30 (d, 1 H, H(5), J = 8.80 Hz);
7.31—7.40 (m, 6 H, Ph, H(5´)); 7.45 (dd, 1 H, H(7), J =
8.12 and 6.80 Hz); 8.38 (d, 1 H, H(5´), J = 6.76 Hz); 8.59 (s,
1 H, H(3´)); 12.33 (s, 1 H, NH).
1ꢀEthylꢀ3ꢀ(indolizinꢀ2ꢀyl)quinoxalinꢀ2ꢀone (5a). Ethyl broꢀ
mide (0.046 mL, 0.62 mmol) was added to a mixture of comꢀ
pound 4a (101 mg, 0.39 mmol), KOH (0.1 g, 1.8 mmol), and
DMSO (1 mL). The reaction mixture was stirred for 5 h and
kept for 2 days. The crystals that precipitated were filtered off
and washed with water, and analytically pure compound 5a was
obtained. The filtrate was poured into water. The crystals that
precipitated were filtered off and washed with water, and an
additional amount of compound 5a was obtained. The latter was
dissolved in chloroform (1 mL), passed through a column
(300×15 mm) packed with silica gel (1 g), and eluted with chloꢀ
roform (40 mL). The solvent was evaporated in vacuo, and anaꢀ
lytically pure compound 5a was obtained in a yield of 0.62 g
(55%), m.p. 167—168 °C. Found (%): C, 74.67; H, 5.26;
N, 14.49. C18H15N3O. Calculated (%): C, 74.80; H, 5.19;
N, 14.53. IR, ν/cm–1: 418, 427, 469, 549, 642, 651, 725, 742,
746, 780, 808, 1115, 1150, 1191, 1246, 1304, 1371, 1498, 1543,
1581, 1633, 1648. 1H NMR, δ: 1.32 (dd, 3 H, CH3, J = 7.28 and
6.94 Hz); 4.48 (dq, 2 H, CH2, J = 7.28 and 6.94 Hz); 6.57 (dd,
1 H, H(6´), J = 6.52 and 6.16 Hz); 6.73 (dd, 1 H, H(7´), J = 6.52
and 6.48 Hz); 7.24 (s, 1 H, H(1´)); 7.37—7.44 (m, 1 H, H(6));
7.44 (d, 1 H, H(8´), J = 8.92 Hz); 7.58—7.65 (m, 1 H, H(7));
7.61 (dd, 1 H, H(8), J = 8.7 and 1.7 Hz); 7.86 (dd, 1 H, H(5),
J = 7.88 and 1.0 Hz); 8.32 (d, 1 H, H(5´), J = 7.3 Hz); 8.68 (s,
1 H, H(3´)). 13C NMR, δ: 12.08 (CH3), 36.67 (CH2), 98.97
(C(1´)), 110.88 (C(6´)), 113.97 (C(8)), 116.82 (C(3´)), 117.86
(C(7´)), 119.00 (C(8´)), 123.14 (C(6)), 123.80 (C(2´)), 125.90
(C(5´)), 129.00 (C(5)), 129.32 (C(7)), 131.08 (C(8a)), 131.67
(C(8a´)), 132.70 (C(4a)), 149.44 (C(3)), 152.89 (C(2)).
1,5ꢀBis[3ꢀ(indolizinꢀ2ꢀyl)ꢀ2ꢀoxoquinoxalinꢀ1ꢀyl]ꢀ3ꢀoxaꢀ
pentane (6). 1,5ꢀDibromoꢀ3ꢀoxapentane (49 mg, 0.21 mmol)
was added to a mixture of compound 4a (100 mg, 0.39 mmol),
KOH (0.1 g, 1.8 mmol), and DMSO (2 mL). The reaction
mixture was stirred for 5 h and kept for 2 days. The crystals that
precipitated were filtered off, washed with water, dried, disꢀ
solved in chloroform (1 mL), and passed through a column
(300×15 mm) packed with silica gel (2 g) with the use of chloroꢀ
form (60 mL) as the eluent. The solvent was removed in vacuo,
and analytically pure compound 6 was obtained. The yield was
0.23 g (20%), m.p. 232—234 °C. Found (%): C, 72.85; H, 4.70;
N, 14.26. C36H28N6O3. Calculated (%): C, 72.96; H, 4.76;
N, 14.18. IR, ν/cm–1: 421, 447, 550, 643, 730, 741, 753, 782,
810, 1107, 1120, 1224, 1305, 1364, 1499, 1545, 1603, 1659.
1H NMR, δ: 3.86 (t, 2 H, OCH2, J = 5.63 Hz); 4.49 (t, 2 H,
NCH2, J = 5.63 Hz); 6.57 (ddd, 1 H, H(6´), J = 7.17, 6.14, and
1.03 Hz); 6.77 (dd, 1 H, H(7´), J = 6.66 and 6.65 Hz); 7.22 (s,
1 H, H(1´)); 7.34 (dd, 1 H, H(6), J = 8.19 and 7.17 Hz); 7.45
(dd, 1 H, H(7), J = 7.46 and 7.45 Hz); 7.46 (d, 1 H, H(8´), J =
9.22 Hz); 7.56 (d, 1 H, H(8), J = 8.19 Hz); 7.79 (d, 1 H, H(5),
J = 8.20 Hz); 8.31 (d, 1 H, H(5´), J = 6.15 Hz); 8.63 (s, 1 H,
H(3´)). 13C NMR, δ: 41.43 (NCH2), 67.12 (OCH2), 98.98
(C(1´)), 110.87 (C(6´)), 114.40 (C(8)), 116.79 (C(3´)), 117.84
(C(7´)), 118.99 (C(8´)), 123.13 (C(6)), 123.75 (C(2´)), 125.88
(C(5´)), 128.78 (C(5)), 128.95 (C(7)), 131.67 (C(8a)), 131.81
(C(8a´)), 132.55 (C(4a)), 149.30 (C(3)), 153.36 (C(2)).
1,5ꢀBis[2ꢀoxoꢀ3ꢀ(1ꢀphenylindolizinꢀ2ꢀyl)quinoxalinꢀ1ꢀyl]ꢀ3ꢀ
oxapentane (7) and 1ꢀ(5ꢀbromoꢀ3ꢀoxapentꢀ1ꢀyl)ꢀ3ꢀ(1ꢀphenylꢀ
indolizinꢀ2ꢀyl)quinoxalinꢀ2ꢀone (11). A mixture of compound 4b
(0.40 g, 1.19 mmol), KOH (0.10 g, 1.79 mmol), and dioxane
(10 mL) was refluxed for 5 min. Then 1,5ꢀdibromoꢀ3ꢀoxapentane
(0.17 g, 0.73 mmol) was added. The reaction mixture was reꢀ
fluxed for 12 h, cooled, and poured into water (40 mL). The
crystals that precipitated were filtered off and washed with waꢀ
ter. The resulting mixture of compounds 4b, 7, and 11 was
separated by silica gel column chromatography (m 20 g,
L 100/160µ) using chloroform as the eluent.
The yield of compound
138—140 °C. Found (%): C, 77.29; H, 4.81; N, 11.39.
48H36N6O3. Calculated (%): C, 77.40; H, 4.87; N, 11.28. IR,
7 was 80 mg (18%), m.p.
C
ν/cm–1: 586, 670, 762, 1083, 1123, 1229, 1311, 1528, 1544,
1581, 1602, 1654. 1H NMR, δ: 3.77 (t, 4 H, 2 OCH2, J =
5.48 Hz); 4.40 (t, 4 H, 2 NCH2, J = 5.48 Hz); 6.60 (ddd, 2 H,
2 H(6´), J = 7.56, 6.16, and 1.36 Hz); 6.73 (dd, 2 H, 2 H(7´), J =
7.52 and 6.80 Hz); 7.12—7.40 (m, 16 H, 2 Ph, 2 H(5), 2 H(6),
2 H(5´)); 7.37 (ddd, 2 H, H(7), J = 8.24, 6.88, and 1.40 Hz);
7.46 (d, 2 H, 2 H(8), J = 8.24 Hz); 8.29 (d, 2 H, 2 H(5´), J =
6.84 Hz); 8.49 (s, 2 H, H(3´)).
1ꢀEthylꢀ3ꢀ(3ꢀphenylindolizinꢀ2ꢀyl)quinoxalinꢀ2ꢀone (5b) was
prepared analogously to compound 5a from phenylindolizinꢀ2ꢀ
ylquinoxalinꢀ2ꢀone (4b) (0.2 g, 0.59 mmol). The yield was 0.1 g
(46%), m.p. 167—169 °C. Found (%): C, 78.96; H, 5.40;
N, 11.39. C24H19N3O. Calculated (%): C, 78.88; H, 5.24;
N, 11.50. IR, ν/cm–1: 419, 432, 463, 501, 584, 670, 701, 732,
The yield of compound 11 was 58 mg (10%), m.p.
121—123 °C. Found (%): C, 64.01; H, 4.38; N, 8.43; Br, 16.25.
26H22BrN3O2. Calculated (%): C, 64.12; H, 4.51; N, 8.62;
Br, 16.40. IR, ν/cm–1: 672, 707, 752, 763, 1134, 1185, 1289,
1311, 1497, 1529, 1582, 1601, 1654. 1H NMR, δ: 3.77 (t,
2 H, N(CH2)2OCH2CH2Br, J = 5.48 Hz); 3.77 (t, 2 H,
C